These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9674126)

  • 1. The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis.
    Baillie L; Moir A; Manchee R
    J Appl Microbiol; 1998 May; 84(5):741-6. PubMed ID: 9674126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of anthrax toxin gene expression by the transition state regulator abrB.
    Saile E; Koehler TM
    J Bacteriol; 2002 Jan; 184(2):370-80. PubMed ID: 11751813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.
    Ivins BE; Welkos SL
    Infect Immun; 1986 Nov; 54(2):537-42. PubMed ID: 3021632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus anthracis Virulence Regulator AtxA Binds Specifically to the
    McCall RM; Sievers ME; Fattah R; Ghirlando R; Pomerantsev AP; Leppla SH
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31570528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autogenous regulation of the Bacillus anthracis pag operon.
    Hoffmaster AR; Koehler TM
    J Bacteriol; 1999 Aug; 181(15):4485-92. PubMed ID: 10419943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of recombinant lethal factor of
    Gholami M; Moghbeli M; Kafilzadeh F; Kargar M; Torbati MB; Tavizi A; Bellevile S; Hatami J; Eslami Z
    Prep Biochem Biotechnol; 2021; 51(1):9-15. PubMed ID: 32393098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    Liang X; Zhu J; Zhao Z; Zheng F; Zhang H; Wei J; Ji Y; Ji Y
    Front Cell Infect Microbiol; 2017; 7():203. PubMed ID: 28603695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis genetics and virulence gene regulation.
    Koehler TM
    Curr Top Microbiol Immunol; 2002; 271():143-64. PubMed ID: 12224521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis.
    Uchida I; Makino S; Sekizaki T; Terakado N
    Mol Microbiol; 1997 Mar; 23(6):1229-40. PubMed ID: 9106214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative sigma factor sigmaH is required for toxin gene expression by Bacillus anthracis.
    Hadjifrangiskou M; Chen Y; Koehler TM
    J Bacteriol; 2007 Mar; 189(5):1874-83. PubMed ID: 17189374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain.
    Cataldi A; Labruyère E; Mock M
    Mol Microbiol; 1990 Jul; 4(7):1111-7. PubMed ID: 2122174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis.
    Vetter SM; Schlievert PM
    Biochemistry; 2007 Jun; 46(25):7343-52. PubMed ID: 17536838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pag gene expression in Bacillus anthracis: use of a pag-lacZ transcriptional fusion.
    Cataldi A; Fouet A; Mock M
    FEMS Microbiol Lett; 1992 Nov; 77(1-3):89-93. PubMed ID: 1459423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis.
    Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis.
    Uchida I; Hornung JM; Thorne CB; Klimpel KR; Leppla SH
    J Bacteriol; 1993 Sep; 175(17):5329-38. PubMed ID: 8366021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
    Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
    Infect Immun; 2003 Feb; 71(2):801-13. PubMed ID: 12540560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heat-inducible Bacillus subtilis bacteriophage phi 105 expression system for the production of the protective antigen of Bacillus anthracis.
    Baillie LW; Moore P; McBride BW
    FEMS Microbiol Lett; 1998 Jun; 163(1):43-7. PubMed ID: 9631544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cloning and expression of determinants of Bacillus anthracis protective antigen in Escherichia coli, Bacillus subtilis, and Bacillus anthracis cells].
    Tedikov VM; Dobritsa AP
    Mol Gen Mikrobiol Virusol; 1993; (2):13-6. PubMed ID: 8515744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis.
    Hoffmaster AR; Koehler TM
    Infect Immun; 1997 Aug; 65(8):3091-9. PubMed ID: 9234759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo Bacillus anthracis gene expression requires PagR as an intermediate effector of the AtxA signalling cascade.
    Mignot T; Couture-Tosi E; Mesnage S; Mock M; Fouet A
    Int J Med Microbiol; 2004 Apr; 293(7-8):619-24. PubMed ID: 15149039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.